SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001618835-23-000017
Filing Date
2023-03-17
Accepted
2023-03-16 19:07:00
Documents
12
Period of Report
2023-03-15
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K evfm-20230315.htm   iXBRL 8-K 31986
  Complete submission text file 0001618835-23-000017.txt   158474

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT evfm-20230315.xsd EX-101.SCH 1896
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT evfm-20230315_lab.xml EX-101.LAB 23892
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT evfm-20230315_pre.xml EX-101.PRE 12519
6 EXTRACTED XBRL INSTANCE DOCUMENT evfm-20230315_htm.xml XML 4126
Mailing Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130
Business Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130 (858) 550-1900
Evofem Biosciences, Inc. (Filer) CIK: 0001618835 (see all company filings)

IRS No.: 208527075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36754 | Film No.: 23740264
SIC: 2834 Pharmaceutical Preparations